BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CardioNet (BEAT) PT Raised to $41 at Dougherty & Co
February 23, 2018 8:19 AM ESTDougherty & Co raised its price target on CardioNet (NASDAQ: BEAT) to $41.00 (from $40.00) while maintaining a Buy rating following strong results.
... MoreBioTelemetry (BEAT) Tops Q4 EPS by 8c
February 22, 2018 4:13 PM ESTBioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.32, $0.08 better than the analyst estimate of $0.24. Revenue for the quarter came in at $91.7 million versus the consensus estimate of $88.3 million.
For earnings history and earnings-related data on BioTelemetry (BEAT) click here.
... More